课题基金 / 基金详情

RNA splicing regulates prostate cancer progression to hormone therapy resistant neuroendocrine tumors

RNA splicing regulates prostate cancer progression to hormone therapy resistant neuroendocrine tumors
RNA剪接调节前列腺癌进展为激素治疗耐药的神经内分泌肿瘤
批准号:
370828
负责人:
Dong Xuesen
金额:
$50.99万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2022-09-01

项目摘要

项目成果

Dong Xuesen的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer affects one in every seven men in developed countries and is the second leading cause of cancer-related death in males. The incidence of this disease will grow with significant increases in life expectancy, creating a perpetual burden on o
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Design a Double-Bolt Lock to Control Cancer Cell Growth
  • 批准号:
    443354
  • 项目类别:
    Operating Grants
  • 资助金额:
    $66.32万
  • 财政年份:
    2021
  • 负责人:
    Dong Xuesen
  • 依托单位:
The Androgen Receptor Signaling in Prostate Cancers
Androgen Receptor Corepressors, PSF and p54nrb, in Prostate Cancer
Steroid Receptor Corepressors, PSF and p54nrb, in Prostate Cancer
海外基金